Trial Profile
Reducing Postprandial Hyperglycemia With Adjuvant Premeal Pramlintide and Postmeal Insulin in Children With Type 1 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 16 Jul 2008 Actual end date added form Clinicaltrials.gov.
- 16 Jul 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov.
- 04 Apr 2007 New trial record.